Acorda Therapeutics, Inc. ( ACOR) - Stock Earnings
Stock symbol ACOR is outdated, potentially delisted? Maybe it is available on other exchange?
ACOR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -16.8 million USD | 22.3 million USD |
| 2023Q2 | -9.4 million USD | 29.7 million USD |
| 2023Q3 | -8.9 million USD | 27.7 million USD |
ACOR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -104.0 million USD | 129.1 million USD |
| 2022 | -65.9 million USD | 118.6 million USD |
| 2023 | -16.0 million USD | 111.1 million USD |
ACOR
Price: $0.66
52 week price:
Earnings Per Share: -203.57 USD
P/E Ratio: 5.98
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 250200
Ebitda: -218.1 millionMarket Capitalization: 821028